Long Acting Injectable PrEP & Women- A Conversation About HPTN 084

Join Sinead Delany-Moreltwe, the PI of HPTN 084 in a conversation about the ongoing clinical trial of long-acting PrEP. Dr. Delany-Moreltwe will discuss a range of topics from the impact COVID-19 is having on the trial to what the results of the trial could mean for adolescent girls and young women.  The conversation will be moderated by a member of the HPTN 084 youth community advisory board.  Come join the conversation!